Daily News Summary - 2025-01-27 09:19:42
==================================================

1. DeepSeek R1’s bold bet on reinforcement learning: How it outpaced OpenAI at 3% of the cost
Link: https://venturebeat.com/ai/deepseek-r1s-bold-bet-on-reinforcement-learning-how-it-outpaced-openai-at-3-of-the-cost/

2. We asked OpenAI's o1 about the top AI trends in 2025 — here's a look into our conversation
Link: https://venturebeat.com/ai/we-asked-openais-o1-about-the-top-ai-trends-in-2025-heres-a-look-into-our-conversation/

3. Why 'prosocial AI' must be the framework for designing, deploying and governing AI
Link: https://venturebeat.com/ai/why-prosocial-ai-must-be-the-framework-for-designing-deploying-and-governing-ai/

4. Corstasis Therapeutics Inc. Announces FDA Acceptance of New Drug Application for Bumetanide Nasal Spray
Link: https://venturebeat.com/business/corstasis-therapeutics-inc-announces-fda-acceptance-of-new-drug-application-for-bumetanide-nasal-spray/

5. ImmunoMet Therapeutics Presents Updated Clinical Data from Phase 1b Study of Lixumistat in Pancreatic Cancer at ASCO-GI Meeting
Link: https://venturebeat.com/business/immunomet-therapeutics-presents-updated-clinical-data-from-phase-1b-study-of-lixumistat-in-pancreatic-cancer-at-asco-gi-meeting/

